- Home
- TCRX vs COLA Comparison
TCRX vs COLA Comparison
Compare TCRX & COLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- COLA
- Stock Information
- Founded
- TCRX 2018
- COLA 2024
- Country
- TCRX United States
- COLA Singapore
- Employees
- TCRX N/A
- COLA N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- COLA
- Sector
- TCRX Health Care
- COLA
- Exchange
- TCRX Nasdaq
- COLA NYSE
- Market Cap
- TCRX 90.5M
- COLA 79.8M
- IPO Year
- TCRX 2021
- COLA 2025
- Fundamental
- Price
- TCRX $1.38
- COLA $10.10
- Analyst Decision
- TCRX Strong Buy
- COLA
- Analyst Count
- TCRX 7
- COLA 0
- Target Price
- TCRX $9.86
- COLA N/A
- AVG Volume (30 Days)
- TCRX 396.8K
- COLA 50.4K
- Earning Date
- TCRX 05-06-2025
- COLA 01-01-0001
- Dividend Yield
- TCRX N/A
- COLA N/A
- EPS Growth
- TCRX N/A
- COLA N/A
- EPS
- TCRX N/A
- COLA N/A
- Revenue
- TCRX $4,421,000.00
- COLA N/A
- Revenue This Year
- TCRX $47.30
- COLA N/A
- Revenue Next Year
- TCRX $74.30
- COLA N/A
- P/E Ratio
- TCRX N/A
- COLA N/A
- Revenue Growth
- TCRX N/A
- COLA N/A
- 52 Week Low
- TCRX $1.02
- COLA $9.95
- 52 Week High
- TCRX $9.69
- COLA $10.10
- Technical
- Relative Strength Index (RSI)
- TCRX 42.86
- COLA N/A
- Support Level
- TCRX $1.32
- COLA N/A
- Resistance Level
- TCRX $1.65
- COLA N/A
- Average True Range (ATR)
- TCRX 0.13
- COLA 0.00
- MACD
- TCRX -0.01
- COLA 0.00
- Stochastic Oscillator
- TCRX 14.63
- COLA 0.00
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About COLA COLUMBUS ACQUISITION CORP
Columbus Acquisition Corp is a blank check company.